David Martín Gutiérrez

  • IBBTEC. Albert Einstein, 22; 39011 Santander
  • david.martin@unican.es
  • 942 206 799 ext. 25923
  • Genomic Analysis of Tumour Development
  • Cancer
  • Department of Cell & Molecular Signalling

​David graduated in Biochemistry (2020) in Complutense University of Madrid, where he also studied the master’s degree in Neuroscience (2021), within the specialty of Neurobiology. During this time, he carried out his Final Degree and Final Master thesis, both focused on the characterization of the CB1 cannabinoid receptor interactome, at the Biochemistry and Molecular Biology Department of the Complutense University of Madrid, where he also enjoyed a Grant for Collaboration in University Departments (2019). At the present, he is member of Ignacio Varela’s Lab where he is involved in a project aimed at determining the role of SWI/SNF chromatin remodeling complexes in lung cancer development.

Genomic analysis of tumour development group

Research lines

    • Role of chromatin remodeling genes in cancer development.
    • Use of next-generation sequencing technologies for the identification of new molecular mechanisms of cancer initiation, progression and metastasis.
    • Characterization of the role of intratumor heterogeneity in cancer progression


    • Plan Nacional I+D+I (2012), Investigación Fundamental No Orientada. "Caracterización molecular del papel de los complejos remodeladores de cromatina en el desarrollo tumoral"  SAF2012-31627 IP: Ignacio Varela
    • Fundación Ramón Areces (2014), Ayudas a la investigación en Ciencias de la Vida y la Materia. "Caracterización molecular del papel de la disfunción mitocondrial en el desarrollo tumoral". IP: Ignacio Varela
    • European Research Council (2014). Starting Grant. "Molecular Characterization of the role of intratumor heterogeneity in cancer progression and metastasis". IP: Ignacio Varela
    • Plan Nacional I+D+I (2016), Proyectos RETOS . "Molecular study of the mechanisms of SWI/SNF complexes in tumour progression and their potential exploitation for cancer therapy." SAF2016-76758-R IP: Ignacio Varela

Ignacio Varela Egocheaga (IP)

View more

Rosa Blanco Fernández

View more

Raquel Marqueño Navarro

View more

Natalia Sánchez Collantes

View more